A Comparison between Mygind and Kaiteki positions in administration of drops to the olfactory cleft

Topical nasal steroids are a common treatment intervention for olfactory dysfunction. Penetration of topical treatment to the olfactory cleft (OC), such as nasal drops, is greatly dependent on the position of the head when the treatment is administered. We aimed to examine the penetrance of nasal drops to the OC in two different head positions: the Mygind (lying head back) position and the Kaiteki position.

[1]  M. Caversaccio,et al.  Challenges in topical therapy of chronic rhinosinusitis: The case of nasal drops application - A systematic review. , 2020, Auris, nasus, larynx.

[2]  N. Adappa,et al.  Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence? , 2019, International forum of allergy & rhinology.

[3]  J. Eloy,et al.  Improved delivery of sinus irrigations after middle turbinate resection during endoscopic sinus surgery , 2017, International forum of allergy & rhinology.

[4]  J. Mullol,et al.  Position paper on olfactory dysfunction. , 2017, Rhinology.

[5]  T. Hummel,et al.  The administration of nasal drops in the “Kaiteki” position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects , 2016, European Archives of Oto-Rhino-Laryngology.

[6]  L. Rudmik,et al.  Distribution of topical agents to the paranasal sinuses: an evidence‐based review with recommendations , 2013, International forum of allergy & rhinology.

[7]  T. Hummel,et al.  Intranasal administration of drugs. , 2008, Archives of otolaryngology--head & neck surgery.

[8]  S. Davis,et al.  Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  L. Johansson,et al.  Prevalence of Olfactory Dysfunction: The Skövde Population‐Based Study , 2004, The Laryngoscope.

[10]  J. Klussmann,et al.  Riechstörungen , 2003, HNO.

[11]  D. Leopold,et al.  Techniques of Intranasal Steroid Use , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[12]  T. Hummel,et al.  Local and Systemic Administration of Corticosteroids in the Treatment of Olfactory Loss , 2004, American journal of rhinology.

[13]  P. Stjärne,et al.  Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia , 2003, Acta oto-laryngologica.

[14]  H. Kubba,et al.  The Effect of Head Position on the Distribution of Drops within the Nose , 2000, American journal of rhinology.

[15]  H. Kubba.  How uncomfortable are the various positions recommended for the instillation of nose drops? , 1999, The Journal of Laryngology & Otology.

[16]  Kristine A. Smith,et al.  Delivery of Topical Therapies. , 2016, Advances in oto-rhino-laryngology.

[17]  R. Doty,et al.  Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. , 2012, The Journal of clinical endocrinology and metabolism.

[18]  D. M. M. M. M. Vennemann MD,et al.  The association between smoking and smell and taste impairment in the general population , 2008, Journal of Neurology.

[19]  F. Morén,et al.  A comparative distribution study of two procedures for administration of nose drops. , 1988, Acta oto-laryngologica.